Online inquiry

IVTScrip™ mRNA-Human ADAM9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8897MR)

This product GTTS-WK8897MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAM9 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_003816.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8754
UniProt ID Q13443
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAM9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8897MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25922MR IVTScrip™ mRNA-Human ARHGEF7, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGEF7
GTTS-WK21523MR IVTScrip™ mRNA-Human ANKRD37, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD37
GTTS-WK14059MR IVTScrip™ mRNA-Human ADORA2A, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADORA2A
GTTS-WK19122MR IVTScrip™ mRNA-Human ANKRD36BP2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD36BP2
GTTS-WK15509MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK22067MR IVTScrip™ mRNA-Human ARPC2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARPC2
GTTS-WK15521MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK24774MR IVTScrip™ mRNA-Human ARPP21, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARPP21
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →